journal
Journals Strahlentherapie und Onkologie...

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et Al]

https://read.qxmd.com/read/38324078/intensity-modulated-radiotherapy-alone-compared-with-intensity-modulated-radiotherapy-plus-concurrent-chemotherapy-in-intermediate-risk-nasopharyngeal-carcinoma-a%C3%A2-prospective-multicenter-phase%C3%A2-ii-trial
#21
JOURNAL ARTICLE
Shufang Liao, Bin Zhang, Yixin Su, Yufei Pan, Jian Zhang, Zhenkai Ye, Rongjun Zhang, Xiangyun Kong, Guanjie Qin, Yunyan Mo, Xiaolan Ruan, Jian Liu, Chunqiao Gan, Jinxuan Dai, Ruyun Zhang, Guanhong Luo, Xiaofei Liao, Wei Jiang
BACKGROUND: This study aimed to investigate the clinical benefit of adding concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) patients with an intermediate risk (stage II and T3N0M0). METHODS: A multicenter phase II randomized trial was conducted in intermediate-risk NPC patients. Enrolled patients were previously untreated and aged ranged from 18 to 70 years without severe coexisting diseases...
February 7, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38315236/dosimetric-advantages-for-cardiac-substructures-in-radiotherapy-of-esophageal-cancer-in-deep-inspiration-breath-hold
#22
JOURNAL ARTICLE
Ahmed Allam Mohamed, Melina Nausikaa Douglas, Philipp Bruners, Michael J Eble
BACKGROUND: Radiotherapy is one of the main treatment options for patients with esophageal cancer; however, it has been linked with an increased risk of cardiac toxicities. In the current study, we evaluated the effect of planning the radiation in deep-inspiration breath hold (DIBH) on the dose sparing of cardiac substructures and lung. MATERIALS AND METHODS: In this study, we analyzed 30 radiation therapy plans from 15 patients diagnosed with esophageal cancer planned for neoadjuvant radiotherapy...
February 5, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38315235/-improved-swallowing-function-after-definitive-radiochemotherapy-for-oropharyngeal-and-hypopharyngeal-cancers-by-sparing-the-pharyngeal-constrictor-muscles
#23
JOURNAL ARTICLE
Alexander M Ziebolz
No abstract text is available yet for this article.
February 5, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38296845/radiochemotherapy-and-interstitial-brachytherapy-for-cervical-cancer-clinical-results-and-patient-reported-outcome-measures
#24
JOURNAL ARTICLE
Johanna Alfrink, Thomas Aigner, Hermann Zoche, Luitpold Distel, Gerhard G Grabenbauer
OBJECTIVE: To evaluate clinical results and long-term patient-reported outcome measures (PROMs) on quality of life in cervical cancer patients following radiochemotherapy (RCT) and brachytherapy (BT) as definitive treatment. MATERIALS AND METHODS: Between 2003 and 2023, a total of 132 patients with advanced cervical cancer were evaluated for possible treatment. Patients treated by postoperative RCT, palliative radiotherapy, and those treated for recurrent disease were excluded...
January 31, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38289360/excellent-long-term-pain-response-and-local-control-following-postoperative-radiotherapy-in-patients-with-multiple-myeloma
#25
JOURNAL ARTICLE
Justus Kaufmann, Annika Ute Täubl, Eirini Nikolaidou, Alexander Rühle, Anne Hopprich, Daniel Wollschläger, Arnulf Mayer, Nils Henrik Nicolay, Heinz Schmidberger, Tilman Bostel
PURPOSE: Multiple myeloma is associated with osteolytic bone lesions, often requiring surgery of the spine and postoperative radiotherapy (RT). Although common, data for clinical and informed decision-making are sparse. In this monocentric retrospective study, we aim to report the outcome of patients who underwent spinal surgery and postoperative RT due to multiple myeloma. METHODS: A total of 54 patients with multiple myeloma who underwent prior spinal surgery and postoperative RT at our institution between 2009 and 2020 were analyzed...
January 30, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38289359/-fifteen-year-outcomes-after-monitoring-surgery-or-radiotherapy-for-prostate-cancer
#26
JOURNAL ARTICLE
Simon K B Spohn, Anca-Ligia Grosu
No abstract text is available yet for this article.
January 30, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38285172/ulcerating-skin-lesions-from-blastic-plasmacytoid-dendritic-cell-neoplasm-responding-to-low-dose-radiotherapy-a%C3%A2-case-report-and-literature-review
#27
JOURNAL ARTICLE
Elgin Hoffmann, Simon Böke, Chiara De-Colle, Claudia Lengerke, Karim-Maximilian Niyazi, Cihan Gani
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that can manifest with skin nodules and erythematous plaques. In most cases BPDCN progresses rapidly, causing multiple skin lesions and also affecting internal organs and bone marrow, warranting initiation of systemic therapies or hematopoietic stem cell transplantation (HCT). Although not curative, radiotherapy for isolated lesions might be indicated in case of (imminent) ulceration and large or symptomatic lesions. To this end, doses of 27...
January 29, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38273135/prostate-cancer-and-elective-nodal-radiation-therapy-for-cn0-and-pn0-a%C3%A2-never-ending-story-recommendations-from-the-prostate-cancer-expert-panel-of-the-german-society-of-radiation-oncology-degro
#28
REVIEW
S A Koerber, S Höcht, D Aebersold, C Albrecht, D Boehmer, U Ganswindt, N-S Schmidt-Hegemann, T Hölscher, A-C Mueller, P Niehoff, J C Peeken, M Pinkawa, B Polat, S K B Spohn, F Wolf, C Zamboglou, D Zips, T Wiegel
For prostate cancer, the role of elective nodal irradiation (ENI) for cN0 or pN0 patients has been under discussion for years. Considering the recent publications of randomized controlled trials, the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO) aimed to discuss and summarize the current literature. Modern trials have been recently published for both treatment-naïve patients (POP-RT trial) and patients after surgery (SPPORT trial). Although there are more reliable data to date, we identified several limitations currently complicating the definitions of general recommendations...
January 25, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38267589/treatment-related-pneumonitis-after-thoracic-radiotherapy-chemoradiotherapy-combined-with-anti-pd-1-monoclonal-antibodies-in-advanced-esophageal-squamous-cell-carcinoma
#29
JOURNAL ARTICLE
Xiaoyan Lv, Yajing Wu, Qihui Li, Chen Zheng, Qiang Lin, Qingsong Pang, Min Zhao, Jiandong Zhang, Jun Wang
PURPOSE: This study aims to evaluate the risk factors of treatment-related pneumonitis (TRP) following thoracic radiotherapy/chemoradiotherapy combined with anti-PD‑1 monoclonal antibodies (mAbs) in patients with advanced esophageal squamous cell carcinoma (ESCC). METHODS: We retrospectively reviewed 97 patients with advanced ESCC who were treated with thoracic radiotherapy/chemoradiotherapy combined with anti-PD‑1 mAbs. Among them, 56 patients received concurrent radiotherapy with anti-PD‑1 mAbs and 41 patients received sequential radiotherapy with anti-PD‑1 mAbs...
January 24, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38182832/-the-mirage-trial-mri-guided-stereotactic-body-radiotherapy-for-prostate-cancer-precision-at-its-best
#30
JOURNAL ARTICLE
Felix Ehret
No abstract text is available yet for this article.
January 5, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38180495/-prophylactic-radiation-therapy-versus-standard-of-care-for-patients-with-high-risk-asymptomatic-bone-metastases
#31
JOURNAL ARTICLE
Manuel Guhlich, Stefan Rieken
No abstract text is available yet for this article.
January 5, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38180494/six-year-outcomes-of-robot-assisted-radical-prostatectomy-versus-volumetric-modulated-arc-therapy-for-localized-prostate-cancer-a%C3%A2-propensity-score-matched-analysis
#32
JOURNAL ARTICLE
Michio Noda, Satoru Taguchi, Kenshiro Shiraishi, Tetsuya Fujimura, Akihiro Naito, Taketo Kawai, Jun Kamei, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Tohru Nakagawa, Hideomi Yamashita, Keiichi Nakagawa, Osamu Abe, Hiroshi Fukuhara, Haruki Kume
BACKGROUND: Although robot-assisted radical prostatectomy (RARP) and intensity-modulated radiotherapy are the leading respective techniques of prostatectomy and radiotherapy for localized prostate cancer, almost no study has directly compared their outcomes; none have compared mortality outcomes. METHODS: We compared 6‑year outcomes of RARP (n = 500) and volumetric modulated arc therapy (VMAT, a rotational intensity-modulated radiotherapy, n = 360) in patients with cT1-4N0M0 prostate cancer...
January 5, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38180493/the-role-of-artificial-intelligence-in-informed-patient-consent-for-radiotherapy-treatments-a%C3%A2-case-report
#33
JOURNAL ARTICLE
M Moll, G Heilemann, Dietmar Georg, D Kauer-Dorner, P Kuess
Recent advancements in large language models (LMM; e.g., ChatGPT (OpenAI, San Francisco, California, USA)) have seen widespread use in various fields, including healthcare. This case study reports on the first use of LMM in a pretreatment discussion and in obtaining informed consent for a radiation oncology treatment. Further, the reproducibility of the replies by ChatGPT 3.5 was analyzed. A breast cancer patient, following legal consultation, engaged in a conversation with ChatGPT 3...
January 5, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38180492/stereotactic-body-radiotherapy-sib-vmat-technique-to-dominant-intraprostatic-lesion-dil-for-localized-prostate-cancer-a%C3%A2-dose-escalation-trial-destroy-4
#34
JOURNAL ARTICLE
Francesco Deodato, Milena Ferro, Paolo Bonome, Donato Pezzulla, Carmela Romano, Milly Buwenge, Savino Cilla, Alessio Giuseppe Morganti, Gabriella Macchia
PURPOSE: DESTROY-4 (DOSE-ESCALATION STUDY OF STEREOTACTIC BODY RADIATION THERAPY) was a Phase I trial aimed to evaluate the safety and the feasibility of escalating doses of stereotactic body radiation therapy (SBRT) on MRI-defined Dominant Intraprostatic Lesion (DIL) in low- and intermediate-risk pCa patients using a simultaneous integrated boost-volumetric arc therapy (SIB-VMAT) technique. METHODS: Eligible patients included those with low- and intermediate-risk prostate carcinoma (NCCN risk classes) and an International Prostatic Symptoms Score (IPSS) ≤ 15...
January 5, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38177701/biological-treatment-evaluation-in-thermoradiotherapy-application-in-cervical-cancer-patients
#35
JOURNAL ARTICLE
H P Kok, T D Herrera, J Crezee
BACKGROUND: Hyperthermia treatment quality is usually evaluated by thermal (dose) parameters, though hyperthermic radiosensitization effects are also influenced by the time interval between the two modalities. This work applies biological modelling for clinical treatment evaluation of cervical cancer patients treated with radiotherapy plus hyperthermia by calculating the equivalent radiation dose (EQDRT , i.e., the dose needed for the same effect with radiation alone). Subsequent analyses evaluate the impact of logistics...
January 4, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38165456/post-mastectomy-reirradiation-for-ipsilateral-t3n0m0-breast-tumor-relapse-a%C3%A2-population-based-study
#36
JOURNAL ARTICLE
Pierre Loap, Youlia Kirova
INTRODUCTION: Post-mastectomy radiotherapy is commonly recommended for T3N0M0 breast cancer, particularly in the presence of adverse prognostic factors. However, for T3N0M0 ipsilateral recurrences following breast-conserving surgery and adjuvant radiotherapy, the situation is distinct. Recurrence alone signifies a negative prognostic factor. Moreover, tumor relapses within previously irradiated areas exhibit enhanced radioresistance, and reirradiation of the chest wall carries an escalated risk of radiation-induced toxicity...
January 2, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38163834/quality-requirements-for-mri-simulation-in-cranial-stereotactic-radiotherapy-a%C3%A2-guideline-from-the-german-taskforce-imaging-in-stereotactic-radiotherapy
#37
REVIEW
Florian Putz, Michael Bock, Daniela Schmitt, Christoph Bert, Oliver Blanck, Maximilian I Ruge, Elke Hattingen, Christian P Karger, Rainer Fietkau, Johanna Grigo, Manuel A Schmidt, Tobias Bäuerle, Andrea Wittig
Accurate Magnetic Resonance Imaging (MRI) simulation is fundamental for high-precision stereotactic radiosurgery and fractionated stereotactic radiotherapy, collectively referred to as stereotactic radiotherapy (SRT), to deliver doses of high biological effectiveness to well-defined cranial targets. Multiple MRI hardware related factors as well as scanner configuration and sequence protocol parameters can affect the imaging accuracy and need to be optimized for the special purpose of radiotherapy treatment planning...
January 2, 2024: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38157016/stereotactic-body-radiotherapy-sbrt-re-irradiation-for-local-failures-following-radical-prostatectomy-and-post-operative-radiotherapy
#38
JOURNAL ARTICLE
Wojciech Majewski, Marcin Miszczyk, Donata Graupner, Bartłomiej Goc, Gregor Goldner, Aleksandra Napieralska
PURPOSE: Local recurrences after radical prostatectomy (RP) and postoperative radiotherapy (RT) are challenging for salvage treatment. Retrospective analysis of own experiences with salvage re-irradiation was performed. METHODS: The study included all consecutive patients treated with salvage stereotactic body radiotherapy (sSBRT) for prostate bed recurrence following RP and postoperative RT at a single tertiary center between 2014 and 2021. Treatment toxicity defined as the occurrence of CTCAE grade ≥ 2 genito-urinary (GU) or gastro-intestinal (GI) adverse events (AEs) was assessed...
December 29, 2023: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38153435/is-a%C3%A2-total-dose-of-54%C3%A2-gy-with-radiochemotherapy-sufficient-for-treatment-of-intermediate-risk-volumes-in-nasopharyngeal-cancer
#39
JOURNAL ARTICLE
Meltem Dağdelen, Tuba Kurt Çatal, Songül Çavdar Karaçam, Emine Sedef Akovalı, Sevda Kanat, Halil Cumhur Yıldırım, Ömer Erol Uzel
BACKGROUND: The mainstay treatment of nasopharyngeal cancer (NPC) is radiation therapy (RT). The doses and volumes may differ from center to center. Most studies and guidelines recommend a total dose of 60 Gy for elective nodal and peritumoral volume treatment. This retrospective analysis aimed to analyze whether a dose reduction to 54 Gy to this volume would be associated with a higher risk of recurrence. METHODS: A total of 111 patients treated by intensity-modulated radiotherapy (IMRT) and concurrent chemotherapy were retrospectively analyzed...
December 28, 2023: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
https://read.qxmd.com/read/38108835/can-interventional-radiotherapy-brachytherapy-be-an-alternative-to-surgery-in-early-stage-oral-cavity-cancer-a%C3%A2-systematic-review
#40
REVIEW
Lorena Draghini, Valentina Lancellotta, Bruno Fionda, Martina De Angeli, Patrizia Cornacchione, Mariangela Massaccesi, Fabio Trippa, Gyoergy Kovács, Alessio Giuseppe Morganti, Francesco Bussu, Roberto Iezzi, Luca Tagliaferri
PURPOSE: Brachytherapy (BT), also known as interventional radiotherapy (IRT), has proven its utility in the treatment of localized tumors. The aim of this review was to examine the efficacy of modern BT in early-stage oral cavity cancer (OCC) in terms of local control (LC), overall survival (OS), disease-free survival (DFS), cancer-specific survival (CSS), and safety. METHODS: The SPIDER framework was used, with sample (S), phenomena of interest (PI), design (D), evaluation (E), and research type (R) corresponding to early-stage oral cavity cancer (S); BT (PI); named types of qualitative data collection and analysis (D); LC, OS, DFS, CSS, and toxicity (E); qualitative method (R)...
December 18, 2023: Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft ... [et Al]
journal
journal
29228
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.